The Steward House at Silver Hill in New Canaan, CT.
Mental health problems and addiction are “equal opportunity” destroyers of lives, dreams and families. Even the strongest, most ambitious and resilient among us struggle with mental health and substance use problems. Even those responsible for overseeing large organizations or accountable for the welfare of many, those who command respect and trust—the stewards of our society. Someone like you.
The Steward House at Silver Hill, in New Canaan, CT., a collaboration between Yale Medicine, Yale New Haven Health and Silver Hill Hospital, is a transitional living program exclusively for leaders to rediscover and strengthen the skills necessary for long-term recovery and wellness. Our program allows you to undergo intensive therapy free from major stressors and triggers in a compassionate environment designed around you. Entrusted with your care, our world-renowned team of experts provides professional treatment to steward you through recovery.
At The Steward House, instead of you conforming to an established treatment, your care conforms to your individual needs. Our expert team of mental health professionals will develop an individualized treatment plan centered in evidence-based medicine and specific to you. Your plan is based on a comprehensive psychosocial assessment that guides the creation of your 30-day therapy protocol.
Your Care Team
Samuel Ball, PhD, is the Director of Psychology and Executive Programs. He leads The Steward House, a collaborative program of Silver Hill Hospital, Yale New Haven Health, and Yale School of Medicine where he is Professor of Psychiatry and Assistant Chair for Education and Career Development. Dr. Ball is a licensed clinical psychologist and national expert in the diagnosis and treatment of substance use disorders (SUD). He has held numerous clinical, educational, and research leadership roles within Yale’s Department of Psychiatry, The APT Foundation, and the National Center on Addiction and Substance Abuse.
Dr. Ball is an expert in cognitive behavioral therapy, and he also led the national clinician and supervisory training for motivational interviewing in the NIDA Clinical Trials Network. He has worked with numerous community treatment programs to establish evidence-based therapy practices, dual diagnosis services, and clinical trials research. His diagnostic research focuses on the assessment of co-occurring psychiatric disorders among SUD patients, particularly mood and personality disorders. His treatment research focuses on cognitive behavioral and motivational models of psychotherapy for SUD and dual diagnosis patients. He is the developer of Dual Focus Schema Therapy, a specialized treatment for addicted patients with personality disorders and evaluated its efficacy through randomized clinical trials within methadone maintenance, residential treatment, and a homeless drop-in center.